These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 8751262
1. Cefetamet pivoxil: comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens. Speciale A, Caccamo F, Blandino G, Giacchi GT, Aleo G, Nicoletti G. Chemotherapy; 1996; 42(1):1-10. PubMed ID: 8751262 [Abstract] [Full Text] [Related]
2. Third generation oral cephalosporins: comparative in vitro kinetics. Speciale A, Blandino G, Nicoletti G. J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112 [Abstract] [Full Text] [Related]
3. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Bryson HM, Brogden RN. Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677 [Abstract] [Full Text] [Related]
4. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Schito GC, Pesce A, Debbia EA. Drugs; 1994 Apr; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761 [Abstract] [Full Text] [Related]
5. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production. Blandino G, Aleo G, Caccamo F, Nicolosi VM, Siracusa V, Speciale A. J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715 [Abstract] [Full Text] [Related]
6. In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics. Kayser FH. Infection; 1994 Jun; 22(5):370-5. PubMed ID: 7843823 [Abstract] [Full Text] [Related]
8. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Bauernfeind A, Jungwirth R. Infection; 1991 Sep; 19(5):353-62. PubMed ID: 1800377 [Abstract] [Full Text] [Related]
9. [In vitro activity of cefetamet compared with other antimicrobial agents against bacteria isolated from respiratory tract infections]. Mendes CM. Rev Assoc Med Bras (1992); 1997 Sep; 43(1):47-52. PubMed ID: 9224992 [Abstract] [Full Text] [Related]
10. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae. Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G. Chemotherapy; 1992 Sep; 38(1):36-45. PubMed ID: 1618002 [Abstract] [Full Text] [Related]
11. [Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III]. Matsumoto Y, Ishihara R, Suzuki Y, Nishinari C, Ishii Y, Nakane Y, Endo H. Jpn J Antibiot; 1999 Jun; 52(6):469-77. PubMed ID: 10481811 [Abstract] [Full Text] [Related]
12. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil. Angehrn P, Hohl P, Then RL. Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597 [Abstract] [Full Text] [Related]
13. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase. Tzouvelekis LS, Prinarakis EE, Gazouli M, Miriagou V, Tzelepi E, Legakis NJ. Chemotherapy; 1996 Jun; 42(5):324-8. PubMed ID: 8874970 [Abstract] [Full Text] [Related]
14. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC. Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565 [Abstract] [Full Text] [Related]
15. [Antimicrobial activity of cefetamet against clinically isolated microbial strains collected from urban RTI patients]. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y. Jpn J Antibiot; 1992 Nov; 45(11):1451-9. PubMed ID: 1494228 [Abstract] [Full Text] [Related]
16. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections]. Shimada J, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Deguchi K. Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588 [Abstract] [Full Text] [Related]
17. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y. Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [Abstract] [Full Text] [Related]
18. [Antibacterial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections (II)]. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukumoto T. Jpn J Antibiot; 1994 Dec; 47(12):1753-61. PubMed ID: 7877255 [Abstract] [Full Text] [Related]
19. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. Tempera G, Furneri PM, Carlone NA, Cocuzza C, Rigoli R, Musumeci R, Pilloni AP, Prenna M, Tufano MA, Tullio V, Vitali LA, Nicoletti G. J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418 [Abstract] [Full Text] [Related]
20. Cefpodoxime: comparable evaluation with other orally available cephalosporins. With a note on the role of beta-lactamases. Cullmann W, Dick W. Zentralbl Bakteriol; 1990 Sep; 273(4):501-17. PubMed ID: 2248685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]